Plasmodium falciparum sporozoite and liver stage antigens

The invention provides novel malaria polypeptides expressed at the preerythrocytic stage of the malaria life-cycle. The antigens can be utilized to induce an immune response against malaria in a mammal by administering the antigens in vaccine formulations or expressing the antigens in DNA or other n...

Full description

Saved in:
Bibliographic Details
Main Authors SEDEGAH, MARTHA, LIMBACH, KEITH, AGUIAR, JOAO, RICHIE, THOMAS
Format Patent
LanguageEnglish
Published 08.03.2012
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention provides novel malaria polypeptides expressed at the preerythrocytic stage of the malaria life-cycle. The antigens can be utilized to induce an immune response against malaria in a mammal by administering the antigens in vaccine formulations or expressing the antigens in DNA or other nucleic acid expression systems delivered as a vaccine formulation.
Bibliography:Application Number: AU20100315868